The Department Of Pharmaceutical (Dop) Has Rejected The Review Application Filed By Ranbaxy Laboratories Ltd (Now Sun Pharmaceutical Industries Limited) Against The Notification S.O. No. 2095(E), Dated 20.08.2014 Issued By The Nppa Fixing The Ceiling Price Of Ciprofloxacin Hydrochloride Injection 200Mg/100Ml.The Applicant Ranbaxy Had Filed A Review Application, Dated 18.09.2014 Under Paragraph 31 Of Dpco, 2013 Against The Notification. But, The Review Application Was Disposed Of By The Dop In Its Review Order No. 31015/53/2015-Pi.I, Dated 14.05.2015.Dissatisfied Over The Dop
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!